{"id":"miconazole","rwe":[],"_fda":{"id":"425303b5-9f9c-efc3-e063-6294a90ae594","set_id":"021b4a31-d7f6-4921-b4b1-cbe832eecd93","openfda":{"upc":["0080196528564"],"unii":["VW4H1CYW1K"],"route":["TOPICAL"],"rxcui":["998461"],"spl_id":["425303b5-9f9c-efc3-e063-6294a90ae594"],"brand_name":["Remedy Antifungal"],"spl_set_id":["021b4a31-d7f6-4921-b4b1-cbe832eecd93"],"package_ndc":["53329-169-79"],"product_ndc":["53329-169"],"generic_name":["MICONAZOLE NITRATE"],"product_type":["HUMAN OTC DRUG"],"substance_name":["MICONAZOLE NITRATE"],"manufacturer_name":["Medline Industries, LP"],"application_number":["M005"],"is_original_packager":[true]},"purpose":["Purpose Antifungal"],"version":"7","stop_use":["Stop use and ask a doctor if irritation occurs there is no improvement within 4 weeks when used for the treatment of athlete's foot or ringworm there is no improvement within 2 weeks when used for the treatment of jock itch"],"warnings":["Warnings For external use only Do not use on children under 2 years of age unless directed by a doctor on scalp or nails When using this product avoid contact with the eyes Stop use and ask a doctor if irritation occurs there is no improvement within 4 weeks when used for the treatment of athlete's foot or ringworm there is no improvement within 2 weeks when used for the treatment of jock itch Keep out of reach of children If swallowed, get medical help or contact a Poison Control center right away."],"do_not_use":["Do not use on children under 2 years of age unless directed by a doctor on scalp or nails"],"when_using":["When using this product avoid contact with the eyes"],"effective_time":"20251029","active_ingredient":["Active ingredient Miconazole nitrate 2.0% w/w"],"inactive_ingredient":["Inactive ingredients Aphanizomenon Flos-Aquae (Algae) Extract, Camellia Sinensis (Green Tea) Leaf Extract, Caprylic/Capric Triglycerides, 7-Dehydrocholesterol, Dipotassium Glycyrrhizate, Ethylene Brassylate, Eugenia Caryophyllus (Clove) Flower Extract, Fragrance, Glycerin, Hydrolyzed Soy Protein, Phospholipids, Silica, Sodium Benzoate, Tocopheryl Acetate, Water, Yeast Ferment Extract, Zea Mays (Corn) Oil, Zea Mays (Corn) Starch"],"storage_and_handling":["Other Information protect from freezing. Avoid excessive heat. do not use if package is damaged keep dry"],"indications_and_usage":["Uses for the treatment of most athlete's foot (tinea pedis), jock itch (tinea cruris), ringworm (tinea corporis) relieves most itching, scaling, cracking, burning, redness, soreness, irritation, discomfort and chafing associated with jock itch"],"dosage_and_administration":["Directions Clean the affected area and dry thoroughly Apply a thin layer of powder over affected area twice daily (morning and night) or as directed by a doctor Supervise children in the use of this product For athlete's foot, pay special attention between spaces in toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily For athlete's foot and ringworm, use daily for 4 weeks For jock itch, use daily for 2 weeks If condition persists longer, consult a doctor This product is not effective on the scalp or nails."],"spl_product_data_elements":["Remedy Antifungal Miconazole Nitrate APHANIZOMENON FLOS-AQUAE GREEN TEA LEAF CAPRYLIC/CAPRIC/LINOLEIC TRIGLYCERIDE 7-DEHYDROCHOLESTEROL GLYCYRRHIZINATE DIPOTASSIUM ETHYLENE BRASSYLATE CLOVE GLYCERIN SOY PROTEIN ISOPROPYL MYRISTATE METHYL DIHYDROJASMONATE (SYNTHETIC) EGG PHOSPHOLIPIDS HYDRATED SILICA SODIUM BENZOATE .ALPHA.-TOCOPHEROL ACETATE VANILLA WATER YEAST CORN OIL STARCH, CORN MICONAZOLE NITRATE MICONAZOLE"],"keep_out_of_reach_of_children":["Keep out of reach of children If swallowed, get medical help or contact a Poison Control center right away."],"package_label_principal_display_panel":["Package Label Package Label"]},"tags":[],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[{"date":"","signal":"VULVOVAGINAL BURNING SENSATION","source":"FDA FAERS","actionTaken":"1670 reports"},{"date":"","signal":"DRUG INEFFECTIVE","source":"FDA FAERS","actionTaken":"1145 reports"},{"date":"","signal":"VULVOVAGINAL PAIN","source":"FDA FAERS","actionTaken":"948 reports"},{"date":"","signal":"VULVOVAGINAL PRURITUS","source":"FDA FAERS","actionTaken":"568 reports"},{"date":"","signal":"CONDITION AGGRAVATED","source":"FDA FAERS","actionTaken":"528 reports"},{"date":"","signal":"VAGINAL HAEMORRHAGE","source":"FDA FAERS","actionTaken":"466 reports"},{"date":"","signal":"VULVOVAGINAL DISCOMFORT","source":"FDA FAERS","actionTaken":"422 reports"},{"date":"","signal":"VULVOVAGINAL SWELLING","source":"FDA FAERS","actionTaken":"304 reports"},{"date":"","signal":"DRUG INTERACTION","source":"FDA FAERS","actionTaken":"297 reports"},{"date":"","signal":"PAIN","source":"FDA FAERS","actionTaken":"269 reports"}],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Disease of liver"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"status":"approved","trials":["NCT06433128","NCT06828458","NCT00805090","NCT03024502","NCT03437005","NCT00769457","NCT06349122","NCT01731574","NCT02847286","NCT04947592","NCT03226418","NCT04847050","NCT00755053","NCT06214273","NCT02057289","NCT00916643","NCT03905447","NCT01230814","NCT01769339","NCT00194324","NCT00078559","NCT03572959","NCT03359070","NCT01119742","NCT02713139","NCT06274554","NCT06869681","NCT04869449","NCT04825275","NCT01993823","NCT02860845","NCT03115073","NCT00385502","NCT06117904","NCT01335373","NCT00061282","NCT04432376","NCT00842504","NCT00361517","NCT00004492","NCT00036166","NCT00526227","NCT03005353","NCT06681090","NCT00835510","NCT05129033","NCT01580878","NCT03583164","NCT06146504","NCT02545452"],"aliases":["Monistat","Micatin","Daktarin"],"patents":[],"pricing":[{"market":"United States","source":"CMS National Average Drug Acquisition Cost (NADAC)","asOfDate":"2024-01-03","unitCost":"$0.0800/GM","priceType":"NADAC","sourceUrl":"https://data.medicaid.gov/dataset/4j6z-xnwq","annualCost":"$29","description":"MICONAZOLE 2% TOPICAL CREAM","retrievedDate":"2026-04-07"}],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=miconazole","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T02:28:41.486334+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T02:28:47.996084+00:00"},"regulatory.us":{"url":"","method":"api_direct","source":"FDA Drugs@FDA","rawText":"","confidence":1,"sourceType":"fda_drugsfda","retrievedAt":"2026-04-20T02:28:40.048474+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=miconazole","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T02:28:48.758448+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T02:28:38.027510+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T02:28:38.027573+00:00"},"safety.safetySignals":{"url":"https://api.fda.gov/drug/event.json","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-20T02:28:50.311585+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Cytochrome P450 51 inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:28:49.364744+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1559/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:28:49.255708+00:00"},"regulatory.fda_application":{"url":"","method":"deterministic","source":"FDA Label","rawText":"M005","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T02:28:38.027584+00:00"}},"allNames":"monistat","offLabel":[],"timeline":[],"aiSummary":"Miconazole (Monistat/Micatin) is one of the most used OTC antifungals, developed by Janssen. Available in topical, vaginal, and buccal formulations. Available generically.","brandName":"Monistat","companyId":"johnson-johnson","ecosystem":[],"mechanism":{"target":"7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase, Malate dehydrogenase cytoplasmic , 5-hydroxytryptamine receptor 6","novelty":"","modality":"Small molecule","drugClass":"Imidazole antifungal","explanation":"","oneSentence":"","technicalDetail":""},"commercial":null,"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:28:52.050524+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"companyName":"Johnson & Johnson (Janssen)","competitors":[],"dataSources":[{"url":"https://data.medicaid.gov/dataset/4j6z-xnwq","name":"CMS National Average Drug Acquisition Cost (NADAC)","fields":["pricing"],"retrievedDate":"2026-04-07"}],"genericName":"miconazole","indications":{"approved":[{"name":"Candidal vulvovaginitis","diseaseId":"candidal-vulvovaginitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Candidiasis of mouth","diseaseId":"candidiasis-of-mouth","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Candidiasis of skin","diseaseId":"candidiasis-of-skin","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Deep mycosis","diseaseId":"deep-mycosis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Diaper rash","diseaseId":"diaper-rash","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Onychomycosis due to dermatophyte","diseaseId":"onychomycosis-due-to-dermatophyte","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Oropharyngeal Candidiasis","diseaseId":"oropharyngeal-candidiasis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pityriasis versicolor","diseaseId":"pityriasis-versicolor","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Tinea corporis","diseaseId":"tinea-corporis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Tinea cruris","diseaseId":"tinea-cruris","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Tinea pedis","diseaseId":"tinea-pedis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06433128","phase":"N/A","title":"Expanded Access to Fosmanogepix for Patients With Serious or Life-threatening Invasive Fungal Infections Who Have no Other Treatment Options","status":"AVAILABLE","sponsor":"Basilea Pharmaceutica","isPivotal":false,"enrollment":0,"indication":"Invasive Fungal Infections","completionDate":""},{"nctId":"NCT06828458","phase":"N/A","title":"Determining Elements of Anti-Fungal Immunity in BURN Patients","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","isPivotal":false,"enrollment":327,"indication":"Burn","completionDate":"2030-09-01"},{"nctId":"NCT00805090","phase":"Phase 1","title":"An Open-Label, Single-Dose Study to Evaluate the Safety and Pharmacokinetics of DIC075V in Subjects With Mild or Moderate Chronic Renal Insufficiency and in Subjects With Mild Chronic Hepatic Impairme","status":"COMPLETED","sponsor":"Javelin Pharmaceuticals","isPivotal":false,"enrollment":37,"indication":"Renal Insufficiency, Chronic, Hepatic Insufficiency","completionDate":"2009-04"},{"nctId":"NCT03024502","phase":"Phase 1","title":"Randomized Clinical Trial of a Mucoadhesive Gel Containing EPP-AF in Patients Diagnosed With Vulvovaginal Candidiasis","status":"UNKNOWN","sponsor":"University of Sao Paulo","isPivotal":false,"enrollment":90,"indication":"Vulvovaginal Candidiasis","completionDate":"2020-06"},{"nctId":"NCT03437005","phase":"Phase 1","title":"Alterations in the Human Microbiome With Commonly Used Topical Medications","status":"RECRUITING","sponsor":"University of California, Davis","isPivotal":false,"enrollment":24,"indication":"Healthy","completionDate":"2026-09-28"},{"nctId":"NCT00769457","phase":"Phase 4","title":"OptiLink HF Study (Optimization of Heart Failure Management Using Medtronic OptiVol® Fluid Status Monitoring and Medtronic CareLink® Network)","status":"COMPLETED","sponsor":"Medtronic Cardiac Rhythm and Heart Failure","isPivotal":false,"enrollment":1002,"indication":"Heart Failure","completionDate":"2014-11"},{"nctId":"NCT06349122","phase":"Phase 4","title":"Screen-and-treat Strategy for Vaginal Flora Abnormalities by Multiplex Molecular Biology Using POC Technology in Pregnant Women at High Risk of Preterm Birth: A Multicentre, Randomized Study (AUTOP2)","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique Hopitaux De Marseille","isPivotal":false,"enrollment":1292,"indication":"Bacterial Vaginosis, Vaginal Dysbiosis","completionDate":"2028-01"},{"nctId":"NCT01731574","phase":"Phase 1","title":"An Open-label, Randomized, Three-period Crossover Trial in Healthy HIV-negative Women to Assess the Drug-drug Interaction Between Dapivirine Vaginal Ring-004 and Miconazole Nitrate","status":"COMPLETED","sponsor":"International Partnership for Microbicides, Inc.","isPivotal":false,"enrollment":36,"indication":"HIV","completionDate":"2013-10"},{"nctId":"NCT02847286","phase":"Phase 1","title":"AN OPEN-LABEL, RANDOMISED TRIAL, WITH A THREE-PERIOD CROSSOVER PART IN HEALTHY HIV-NEGATIVE WOMEN TO ASSESS THE DRUG-DRUG INTERACTION POTENTIAL BETWEEN DAPIVIRINE VAGINAL RING-004, CONTAINING 25 MG OF","status":"COMPLETED","sponsor":"International Partnership for Microbicides, Inc.","isPivotal":false,"enrollment":36,"indication":"HIV- Prevention","completionDate":"2016-11-28"},{"nctId":"NCT04947592","phase":"N/A","title":"Outcome of SD-OCT Guided Oral Anti-fungal Treatment of Fungal Chorioretinitis","status":"UNKNOWN","sponsor":"Benha University","isPivotal":false,"enrollment":10,"indication":"Fungal Retinitis","completionDate":"2022-01"},{"nctId":"NCT03226418","phase":"Phase 2","title":"A Phase II Study of the Impact of Clinicogenetic Risk-Stratified Management on Outcomes of Acute Myeloid Leukemia in Older Patients","status":"COMPLETED","sponsor":"University of Nebraska","isPivotal":false,"enrollment":75,"indication":"Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia","completionDate":"2024-10-01"},{"nctId":"NCT04847050","phase":"Phase 2","title":"A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tum","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","isPivotal":false,"enrollment":19,"indication":"Solid Tumor Malignancy, Hematologic Malignancy","completionDate":"2023-05-25"},{"nctId":"NCT00755053","phase":"Phase 3","title":"An Investigator-blinded, Active-controlled Phase 3 Study to Prove the Non-inferior Efficacy of a Clotrimazole Ovule (500 mg) Versus a Clotrimazole Vaginal Tablet (500 mg) in Vaginal Candidiasis","status":"COMPLETED","sponsor":"Bayer","isPivotal":true,"enrollment":466,"indication":"Clotrimazole, Ovulen","completionDate":"2009-05"},{"nctId":"NCT06214273","phase":"Phase 2","title":"Evaluation of Low Level Diode Diode Versus Topical Chamomile in Management of Chemotherapy Induced Oral Mucositis: Three Arm Randomized Clinical Trial","status":"UNKNOWN","sponsor":"Cairo University","isPivotal":false,"enrollment":45,"indication":"Chemotherapy Induced Oral Mucositis","completionDate":"2024-10"},{"nctId":"NCT02057289","phase":"Phase 1","title":"Micafungin Anti-Fungal Prophylaxis in Immunocompromised Pediatric Patients: A Pharmacokinetic Study","status":"TERMINATED","sponsor":"Children's Hospital Medical Center, Cincinnati","isPivotal":false,"enrollment":9,"indication":"Immunocompromised, Bone Marrow Transplant","completionDate":"2014-11"},{"nctId":"NCT00916643","phase":"Phase 4","title":"Post Marketing Surveillance Study for LDL Apheresis Using H.E.L.P. Therapy","status":"COMPLETED","sponsor":"B. Braun Medical Inc.","isPivotal":false,"enrollment":113,"indication":"Familial Hypercholesterolemia","completionDate":"2009-09"},{"nctId":"NCT03905447","phase":"Phase 2","title":"An Open-label, Pilot Study to Assess Safety, Tolerability, Pharmacokinetics and Effects of Inhaled PC945 in the Pre-emptive Treatment of Aspergillus Fumigatus Colonisation in Lung Transplant Recipient","status":"TERMINATED","sponsor":"Pulmocide Ltd","isPivotal":false,"enrollment":2,"indication":"Aspergillosis, Lung Transplant Infection","completionDate":"2020-06-01"},{"nctId":"NCT01230814","phase":"Phase 2","title":"A Double-Blind, Randomized Trial of Monthly Treatment With Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories Versus Placebo for Preventing Vaginal Infections in HIV-seronegative","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","isPivotal":false,"enrollment":234,"indication":"Bacterial Vaginosis, Candidiasis","completionDate":"2013-08"},{"nctId":"NCT01769339","phase":"Phase 4","title":"Effectiveness and Safety of Daktacort Feminine Care Cream in the Treatment of Vulvar Candidiasis","status":"COMPLETED","sponsor":"Janssen Pharmaceutica","isPivotal":false,"enrollment":115,"indication":"Vulva; Candidiasis","completionDate":"2009-06"},{"nctId":"NCT00194324","phase":"Phase 4","title":"Vaginal Imaging Study to Evaluate the Effect of Exercise on the Distribution of Miconozole Nitrate OVULE","status":"COMPLETED","sponsor":"University of Pennsylvania","isPivotal":false,"enrollment":12,"indication":"Health, Vulvovaginal Candidiasis","completionDate":"2004-10"},{"nctId":"NCT00078559","phase":"Phase 1","title":"The Use of Campath-1H, Tacrolimus, and Sirolimus Followed by Sirolimus Withdrawal in Renal Transplant Patients","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","isPivotal":false,"enrollment":10,"indication":"Kidney Transplantation, Kidney Disease","completionDate":"2010-02"},{"nctId":"NCT03572959","phase":"Phase 4","title":"Management of Pain in Oral Lichen Planus Patients: A Comparative Pilot Study","status":"COMPLETED","sponsor":"Sherine Adel Nasry","isPivotal":false,"enrollment":24,"indication":"Oral Lichen Planus","completionDate":"2017-05-22"},{"nctId":"NCT03359070","phase":"Phase 2","title":"Clinical Study of Non-inferiority (Phase 2), Comparing Dapaconazole (BL123 - Biolab Sanus Farmacêutica Ltda.) Versus Miconazole Nitrate (União Química) in Patients With a Single Lesion of Tinea Cruris","status":"COMPLETED","sponsor":"Galeno Desenvolvimento de Pesquisas Clínicas","isPivotal":false,"enrollment":51,"indication":"Tinea Cruris","completionDate":"2015-05-06"},{"nctId":"NCT01119742","phase":"Phase 1","title":"A Randomized, Double-Blind, Placebo Controlled, Parallel Design, Multiple-Site Study to Evaluate the Clinical Equivalence of Two Generic Butenafine Hydrochloride 1% Creams to Lotrimin Ultra® Cream in ","status":"TERMINATED","sponsor":"Sun Pharmaceutical Industries, Inc.","isPivotal":false,"enrollment":428,"indication":"Interdigital Tinea Pedis","completionDate":"2011-07"},{"nctId":"NCT02713139","phase":"Phase 3","title":"Phase III, Multicenter, Randomized, Parallel, Open Label, Controlled and Comparative Study to Evaluate the Efficacy and Safety of the Association of Clotrimazole 200mg and Metronidazole 0,75% (Colpist","status":"WITHDRAWN","sponsor":"Ache Laboratorios Farmaceuticos S.A.","isPivotal":true,"enrollment":0,"indication":"Sexual Active Women, Vaginal Discharge","completionDate":""},{"nctId":"NCT06274554","phase":"Phase 3","title":"A Prospective, Randomized, Placebo-controlled Trial of Fluconazole in Combination With IL-23 Therapy Versus IL-23 Therapy Alone for the Treatment of Crohn's Disease","status":"RECRUITING","sponsor":"Weill Medical College of Cornell University","isPivotal":true,"enrollment":120,"indication":"Crohn's Disease, Inflammatory Bowel Diseases","completionDate":"2029-12"},{"nctId":"NCT06869681","phase":"Phase 4","title":"Comparison of Efficacy of Sertaconazole Nitrate Cream 2 Percent Vs Clotrimazole 1 Percent for the Treatment of Tinea Pedis.","status":"NOT_YET_RECRUITING","sponsor":"Jinnah Postgraduate Medical Centre","isPivotal":false,"enrollment":100,"indication":"Tinea Pedis","completionDate":"2025-06-15"},{"nctId":"NCT04869449","phase":"EARLY/Phase 1","title":"Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas: A Phase 0 Clinical Trial","status":"TERMINATED","sponsor":"Milton S. Hershey Medical Center","isPivotal":false,"enrollment":1,"indication":"Glioblastoma, Glioblastoma Multiforme","completionDate":"2022-05-12"},{"nctId":"NCT04825275","phase":"EARLY/Phase 1","title":"Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial","status":"TERMINATED","sponsor":"Milton S. Hershey Medical Center","isPivotal":false,"enrollment":7,"indication":"Glioblastoma, Glioblastoma Multiforme","completionDate":"2024-11-06"},{"nctId":"NCT01993823","phase":"Phase 3","title":"A Phase III, Multicenter, Randomized, Double-blind, Parallel Group, Active Treatment-controlled Study Assessing the Safety and Efficacy of G238 Compared to Clotrimazole 1% Otic Solution in Patients Wi","status":"COMPLETED","sponsor":"Salvat","isPivotal":true,"enrollment":190,"indication":"Otomycosis","completionDate":"2014-11"},{"nctId":"NCT02860845","phase":"Phase 4","title":"Multicenter Pilot Study to Compare the Efficacy of a Combination of Vaginal Capsules With Acid Boric, L.Gasseri and L.Rhamnosus Versus the Reference Medication in Patients With Vaginal Candidiasis or ","status":"COMPLETED","sponsor":"Laboratorios Ordesa","isPivotal":false,"enrollment":48,"indication":"Candidiasis, Vaginosis, Bacterial","completionDate":"2017-11-30"},{"nctId":"NCT03115073","phase":"Phase 2","title":"A Phase IIa Randomized, Active-controlled, Double-blind, Dose-escalation Study in Patients With Vulvovaginal Candidiasis to Evaluate Dose Response Relationship of Clinical Efficacy, Safety and Tolerab","status":"COMPLETED","sponsor":"ProFem GmbH","isPivotal":true,"enrollment":84,"indication":"Vulvovaginal Candidiasis (VVC)","completionDate":"2018-07-30"},{"nctId":"NCT00385502","phase":"Phase 2","title":"A Phase II Trial of the Safety, Local Tolerability, and Efficacy of EcoNail™ (Econazole 5%/SEPA® 18% Nail Lacquer) in Onychomycosis of the Great Toenail","status":"COMPLETED","sponsor":"Abeona Therapeutics, Inc","isPivotal":false,"enrollment":40,"indication":"Onychomycosis","completionDate":"2008-06"},{"nctId":"NCT06117904","phase":"NA","title":"Assessing the Effects and Safety of MEBO as Add on Therapy for the Prevention of Radiotherapy-Induced Mucositis","status":"COMPLETED","sponsor":"Beni-Suef University","isPivotal":false,"enrollment":60,"indication":"Radiotherapy Side Effect, Mucositis","completionDate":"2024-07-01"},{"nctId":"NCT01335373","phase":"N/A","title":"Observational Program Neo-Penotran® Forte","status":"COMPLETED","sponsor":"Bayer","isPivotal":false,"enrollment":13024,"indication":"Vaginal Candidiasis, Bacterial Vaginosis","completionDate":"2015-04"},{"nctId":"NCT00061282","phase":"Phase 1","title":"Clotrimazole Enemas for Pouchitis in Children and Adults","status":"TERMINATED","sponsor":"Web","isPivotal":false,"enrollment":11,"indication":"Ulcerative Colitis, Pouchitis","completionDate":"2020-12-01"},{"nctId":"NCT04432376","phase":"Phase 2","title":"Randomized, Double-blind, Phase III Study of the Efficacy and Safety of Miconazole Oil Versus Vehicle Oil in the Treatment of Otomycosis, Followed by an Open-label Safety Evaluation","status":"COMPLETED","sponsor":"Hill Dermaceuticals, Inc.","isPivotal":true,"enrollment":382,"indication":"Otomycosis","completionDate":"2021-11-01"},{"nctId":"NCT00842504","phase":"Phase 1","title":"Alternate Day Micafungin Anti-Fungal Prophylaxis in Immunocompromised Pediatric Patients: A Pharmacokinetic Study","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","isPivotal":false,"enrollment":15,"indication":"Fungal Infection","completionDate":"2009-12"},{"nctId":"NCT00361517","phase":"Phase 3","title":"Using Serum Galactomannan Levels in a Prospective, Randomised, Non-blinded Trial to Guide Early Anti-fungal Therapy in Haematology Patients at Risk of Invasive Aspergillosis.","status":"COMPLETED","sponsor":"Singapore General Hospital","isPivotal":true,"enrollment":47,"indication":"Aspergillosis","completionDate":"2009-06-30"},{"nctId":"NCT00004492","phase":"Phase 1","title":"","status":"COMPLETED","sponsor":"University of North Carolina","isPivotal":false,"enrollment":20,"indication":"Sickle Cell Anemia","completionDate":"2001-09"},{"nctId":"NCT00036166","phase":"Phase 2","title":"An Open-Label, Non-Comparative Study of FK463 for the Treatment of Invasive Aspergillosis","status":"COMPLETED","sponsor":"Astellas Pharma Inc","isPivotal":false,"enrollment":326,"indication":"Aspergillosis","completionDate":"2002-01-31"},{"nctId":"NCT00526227","phase":"NA","title":"Clinical Study to Evaluate System Safety and Clinical Performance of the SecuraTM ICD","status":"COMPLETED","sponsor":"Medtronic Cardiac Rhythm and Heart Failure","isPivotal":false,"enrollment":81,"indication":"Tachyarrhythmias","completionDate":"2008-10"},{"nctId":"NCT03005353","phase":"Phase 2","title":"Randomized Clinical Trial for Treatment of Candidal Vulvovaginitis Using Cumin Seed Extract Vaginal Suppositories.","status":"COMPLETED","sponsor":"Assiut University","isPivotal":true,"enrollment":100,"indication":"Infection, Fungal","completionDate":"2020-01-31"},{"nctId":"NCT06681090","phase":"Phase 1","title":"Effectiveness of Low-Level Laser Therapy and Topical Steroid Therapy in the Management of Oral Lichen Planus","status":"COMPLETED","sponsor":"Al-Azhar University","isPivotal":false,"enrollment":20,"indication":"Oral Lichen Planus","completionDate":"2023-10-29"},{"nctId":"NCT00835510","phase":"Phase 1","title":"A Randomized, Double-Blind, Placebo Controlled, Parallel Design, Multiple-Site Study to Evaluate the Clinical Equivalence of Two Butenafine Hydrochloride 1% Creams in Patients With Interdigital Tinea ","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","isPivotal":false,"enrollment":548,"indication":"Tinea Pedis","completionDate":"2008-12"},{"nctId":"NCT05129033","phase":"NA","title":"A Prospective, Two-center, Clinical Study to Optimize the Treatment for Allergic Bronchopulmonary Aspergillosis (ABPA)","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","isPivotal":false,"enrollment":100,"indication":"Allergic Bronchopulmonary Aspergillosis","completionDate":"2023-12-30"},{"nctId":"NCT01580878","phase":"Phase 1","title":"A Double-Blind, Randomized, Parallel-Group, Vehicle-Controlled, Multicenter Study to Evaluate the Safety and Bioequivalence of a Generic Butenafine Hydrochloride Cream, 1% and Reference Listed Lotrimi","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","isPivotal":false,"enrollment":707,"indication":"Tinea Pedis","completionDate":"2012-12"},{"nctId":"NCT03583164","phase":"Phase 2","title":"Phase IIb Study of F901318 as Treatment of Invasive Fungal Infections Due to Lomentospora Prolificans, Scedosporium Spp., Aspergillus Spp., and Other Resistant Fungi in Patients Lacking Suitable Alter","status":"COMPLETED","sponsor":"F2G Biotech GmbH","isPivotal":false,"enrollment":203,"indication":"Invasive Fungal Infections","completionDate":"2023-02-10"},{"nctId":"NCT06146504","phase":"NA","title":"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of an Anti-Fungal Supplement","status":"COMPLETED","sponsor":"CanXida","isPivotal":false,"enrollment":60,"indication":"Candida Systemic, Candida Albicans Infection","completionDate":"2024-06-28"},{"nctId":"NCT02545452","phase":"Phase 1","title":"A Parallel Group, Randomized, Open-label Study to Investigate the Effect of the Intravaginally Administered Antimycotic Miconazole, Antibiotic Clindamycin, Spermicide Nonoxynol-9, or Co-usage of Tampo","status":"COMPLETED","sponsor":"Bayer","isPivotal":false,"enrollment":52,"indication":"Endometriosis","completionDate":"2016-07-29"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"icon":"","route":"Topical","frequency":"Twice daily (topical) or once daily (vaginal)","formulation":"Cream, Powder, Vaginal suppository, Vaginal cream, Buccal tablet"},"crossReferences":{"chemblId":"CHEMBL1559"},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":3123,"therapeuticAreas":["Infectious Disease"],"biosimilarFilings":[],"firstApprovalDate":"1974-01-01","companionDiagnostics":[],"firstApprovalCountry":"United States","genericManufacturerList":[],"modality":"Small molecule","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1998-01-28T00:00:00.000Z","mah":"SUN PHARMA CANADA","brand_name_local":null,"application_number":"ANDA074444"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1998-07-27T00:00:00.000Z","mah":"MEDTECH PRODUCTS","brand_name_local":null,"application_number":"NDA020827"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2002-10-28T00:00:00.000Z","mah":"MEDTECH PRODUCTS","brand_name_local":null,"application_number":"NDA021261"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2011-04-08T00:00:00.000Z","mah":"GALT PHARMS","brand_name_local":null,"application_number":"NDA022404"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2017-08-21T00:00:00.000Z","mah":"PERRIGO","brand_name_local":null,"application_number":"ANDA074760"},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:28:52.050524+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}